The presence of anti-SARS-CoV-2-S1 RBD-specific antibodies in the samples in 2011–2018 can be due to long-term humoral immunity induced by previous infections of coronaviruses, including SARS-CoV or MERS-CoV. The gene discussed is PSMD1; the disease is infection.